Évaluation des risques liés aux médicaments pendant l’allaitement [Risk assessment of drugs during breastfeeding]
Fiche du document
18 octobre 2023
- doi: 10.53738/REVMED.2023.19.846.1940
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2023.19.846.1940
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/37850807
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_709A7C64E9D48
info:eu-repo/semantics/embargoedAccess , Restricted: cannot be viewed until 2025-04-18 , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Suckling Breast feeding Nursing (Breastfeeding)Citer ce document
E. Cardoso et al., « Évaluation des risques liés aux médicaments pendant l’allaitement [Risk assessment of drugs during breastfeeding] », Serveur académique Lausannois, ID : 10.53738/REVMED.2023.19.846.1940
Métriques
Partage / Export
Résumé
Medication intake during the postpartum period is common with discontinuation of breastfeeding sometimes unnecessarily recommended for fear of adverse effects in the breastfed infant, while exposure through human milk is generally low. The assessment of risks associated with medication intake during breastfeeding is based, among other things, on the little clinical evidence available in specialized sources of information, and on pharmacokinetic principles. A decision-making support is presented to facilitate communication with mothers, foster medication adherence and prevent unnecessary interruption of breastfeeding.